Marlier D
Department of Bird, Rabbit and Rodent Medicine, Faculty of Veterinary Medicine, University of Liège, Bld de Colonster 20, Bat B42, Sart-Tilman, B4000 Liège.
Tijdschr Diergeneeskd. 2010 Mar 1;135(5):194-8.
Vaccination is the best way to control myxomatosis in both pet and production rabbits. Two types of myxomatosis vaccines are commercially available, namely, a vaccine prepared from the Shope fibroma virus (SFV) and one prepared from an attenuated myxoma virus (MV) strain, e.g., SG33. The first one is weakly immunogenic and provides only short-term protection whereas atypical reactions have been described with the second one. This short review describes the vaccine strains and provides some data on the host-virus relationship, resistance, and immunity in myxomatosis. In the last section, recommended myxomatosis vaccination schemes for production and pet animals are presented.
接种疫苗是控制宠物兔和商品兔黏液瘤病的最佳方法。市面上有两种黏液瘤病疫苗，一种是由肖普纤维瘤病毒（SFV）制备的疫苗，另一种是由减毒黏液瘤病毒（MV）株（如SG33）制备的疫苗。第一种免疫原性较弱，只能提供短期保护，而第二种疫苗则出现过非典型反应。这篇简短的综述介绍了疫苗毒株，并提供了一些关于黏液瘤病中宿主与病毒关系、抵抗力和免疫力的数据。在最后一部分，给出了针对商品兔和宠物兔的推荐黏液瘤病疫苗接种方案。
